Navigation Links
K-V Pharmaceutical Use of Cash Collateral Approved by U. S. Bankruptcy Court
Date:8/10/2012

ST. LOUIS, Aug. 10, 2012 /PRNewswire/ -- K-V Pharmaceutical Company ("K-V" or "the Company") announced that the U.S. Bankruptcy Court for the Southern District of New York, the Honorable Judge Allan L. Gropper presiding, today approved on an interim basis the Company's request for the use of cash collateral that was made as part of the Company's voluntary reorganization cases filed under chapter 11 of the U. S. Bankruptcy Code.

"Together with the Court's prior approval of our First Day motions, this authorization of the use of cash collateral is another important step forward, further ensuring that K-V is able to continue operations and focus on the restructuring process," said Greg Divis, President and CEO of K-V Pharmaceutical. "Meanwhile, reaching agreement regarding this matter with our Senior Noteholders sets the stage for continued cooperation toward the development of a plan of restructuring under which K-V will be able to emerge from chapter 11 as a stable and competitive company," Divis concluded.

K-V and certain of its affiliates commenced cases to reorganize under chapter 11 of the U.S. Bankruptcy Code on August 4, 2012. The chapter 11 cases are being jointly administered under case number 12-13346. 

As a further step along the path of its restructuring, the Office of the United States Trustee will hold a meeting to form an Official Committee of Unsecured Creditors on August 13, 2013. Final hearings on the First Day motions, certain other motions as well as a final hearing on the use of cash collateral are scheduled for August 23, 2012.

Updates and additional information can be found at the Company's website www.kvph.com .  In addition, the Company's Claims Administrator, Epiq Bankruptcy Solutions, Inc., maintains a web-based resource where documents from the chapter 11 cases, including the Company's Petitions, can be found, http://dm.epiq
'/>"/>

SOURCE K-V Pharmaceutical Company
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. MAP Pharmaceuticals to Present at Upcoming Investor Conferences
2. Avanir Pharmaceuticals Reports Fiscal 2012 Third Quarter Financial And Business Results
3. K-V Pharmaceutical "First Day" Motions Approved by U.S. Bankruptcy Court
4. Savient Pharmaceuticals Reports Second Quarter 2012 Financial Results
5. Auxilium Pharmaceuticals, Inc. to Present at the Canaccord Genuity 32nd Annual Growth Conference
6. UCF nanoparticle discovery opens door for pharmaceuticals
7. Cadence Pharmaceuticals Reports Second Quarter 2012 Financial Results
8. Inspiration Biopharmaceuticals Expands Industry Expertise with Five New Executive Hires
9. Pharmaceutical, Food Companies Find Presswood Pallet Ideal for BP-Free Transit Packaging
10. Optimer Pharmaceuticals Reports Second Quarter 2012 Financial Results
11. MAP Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... Sterlitech is proud to announce that it ... stable of products . These additional products increase ... membrane filters with surface charges. , “We ... our membrane process testing equipment, and correspondingly, a wider ... explains Sterlitech President Mark Spatz. “The addition of ...
(Date:8/28/2014)... (PRWEB) August 27, 2014 Scientists, researchers, ... for SPIE Laser Damage 2014 symposium. Marking ... for high-power lasers will run 14-17 September. The event ... optics and photonics . , The premier conference for ... laser damage to optical materials will engage researchers and ...
(Date:8/28/2014)... PrimeSource Building Products, Inc., a ... SoundConnect to support their communication needs with ... web conferencing platform GlobalMeet powered by SoundConnect. The ... SoundConnect delivers award winning “results driven” business ... will be utilizing GlobalMeet powered by SoundConnect ...
(Date:8/27/2014)... August 27, 2014 Varian Medical Systems ... its current Salt Lake City manufacturing facility and allow ... Utah to ultimately create 1,000 new full time jobs ... , “Utah is home to hardworking people with immense ... credited with Varian’s success in the manufacturing of our ...
Breaking Biology Technology:Sterlitech Corporation Enhances Its Selection of Flat Sheet Membrane Filters 2Laser Damage to Draw Researchers, Engineers, Scientists to 46th Annual Conference 2Laser Damage to Draw Researchers, Engineers, Scientists to 46th Annual Conference 3PrimeSource Chooses SoundConnect as Collaboration Provider 2Varian Medical Systems Groundbreaking on Facility Expansion Triggers Influx of New Jobs to Salt Lake 2Varian Medical Systems Groundbreaking on Facility Expansion Triggers Influx of New Jobs to Salt Lake 3
... MISSISSAUGA, ON, Dec. 14 /PRNewswire-FirstCall/ - YM BioSciences Inc. ... life sciences product development company that identifies and advances ... stages of development, today announced that it has priced ... a price to the public of $1.60 per share. ...
... CAMBRIDGE, Mass., Dec. 14, 2010 Tolerx, Inc., a ... and cancer by modulating T cell activity, today announced ... to assess the safety, tolerability, pharmacokinetic, and pharmacodynamic profiles ... immune system by enabling T cells to more effectively ...
... Cambridge, Mass., December 6, 2010 Utilizing a century-old ... at Harvard University have demonstrated, for the first time, ... collaboration with researchers from Hamamatsu Photonics in Hamamatsu City, ... University of Magdeburg, Germany, the advance has a wide ...
Cached Biology Technology:YM BIOSCIENCES PRICES $40 MILLION PUBLIC OFFERING 2YM BIOSCIENCES PRICES $40 MILLION PUBLIC OFFERING 3Tolerx Initiates Phase 1 Clinical Trial of TRX518, a First-in-Class anti-GITR Antibody for the Treatment of Cancer 2Tolerx Initiates Phase 1 Clinical Trial of TRX518, a First-in-Class anti-GITR Antibody for the Treatment of Cancer 3Capasso lab demonstrates highly unidirectional 'whispering gallery' microlasers 2
(Date:8/28/2014)... to Research Careers) Program has announced the travel award ... October 18 22, 2014 in San Diego, California. ... of students, post doctorates and scientists from underrepresented groups ... to encourage the participation of young scientists at the ... conferred 16 awards totaling $29,600., The FASEB MARC Program ...
(Date:8/28/2014)... Researchers at the University of Minnesota have developed ... to be used for muscle regeneration research as well ... FSHD. , The research is published in the current ... There is no treatment for FSHD, which is thought ... muscular dystrophy. FSHD is an unusual genetic disorder because, ...
(Date:8/28/2014)... support of peer groups and clinicians is critical ... to recent University of Georgia research. , A ... County area determined that role models for successful ... of infants. , "Mothers who received that support ... said study co-author Alex Anderson, an associate professor ...
Breaking Biology News(10 mins):UMN researchers find animal model for understudied type of muscular dystrophy 2Breastfeeding study shows need for effective peer counseling programs 2
... low intake of folate and vitamin B12 increases the ... among nearly 3,000 middle-aged and elderly Finnish subjects. On ... an increased risk for the metabolic syndrome. Based on ... separate depressive subtypes with different etiologies in terms of ...
... This press release is available in Spanish . ... of amino acids and they play a fundamental role in ... in genes; they, therefore, carry out numerous functions in an ... material), bioregulating (they form part of enzymes) and a long ...
... how life began on a molecular level has been a ... on a possible mechanism by which life may have gotten ... early Earth. Researchers have proposed several competing theories for ... before the first genes or living cells came to be. ...
Cached Biology News:Lack of nutrients and metabolic syndrome linked to different subtypes of depression 2Using computational biology for the annotation of proteins 2Using computational biology for the annotation of proteins 3Model sheds light on the chemistry that sparked the origin of life 2
... Tissue Staining Kits are intended for localization ... histological and cytological specimens. These kits may ... by either R&D Systems or by other ... formation of the Avidin-Biotin Complex (ABC) with ...
... Designed specifically for high efficiency ... Low toxicity reagent proven to ... range of cell types. Results ... 95% of target gene expression. ...
... Purification Protocols covers a wide range of ... and experienced researchers in all areas of ... from the books preface illustrates just how ... research library., The chapters introduce the theoretical ...
... jetSI-ENDO is an easy-to-use siRNA transfection reagent ... endogenous genes in a variety of cell ... with an optimized, straightforward protocol. High levels ... obtained following transfection of 20 to 100 ...
Biology Products: